Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2011


To view an abstract, select an author from the vertical list on the left.

2011 Grants - Pahan

TLR2, a New Therapeutic Target for Microglial Activation in Alzheimer's Disease

Kalipada Pahan, Ph.D.
Rush University Medical Center
Chicago, IL

2011 Investigator – Initiated Research Grant

Microglia are a type of cell in the brain that perform many of the functions of the immune system. They also secrete hormone-like compounds that promote the survival of nerve cells. However, microglia can become excessively activated, leading to inflammation and damage in the brain. Indeed, excessive activation of microglia is a characteristic feature of Alzheimer's disease.

The mechanisms of microglia activation in Alzheimer's disease are not well understood, but it has been shown that they are activated by beta-amyloid, a protein fragment that is the main component of amyloid plaques. In recent years, scientists have characterized some of the proteins on the surface of microglia that recognize beta-amyloid. These proteins are known as the toll-like receptors (TLRs), and they are important for activation of the immune system during infection.

Kalipada Pahan, Ph.D, and colleagues have found that signaling through a specific TLR, TLR2, is essential for activation of microglia by beta-amyloid, even though beta-amyloid does not directly bind to TLR2. They have proposed a series of molecular studies to determine the proteins on the surface of microglial cells that couple the binding of beta-amyloid to the TLR2 signaling pathway. They also plan to develop a drug-like compound that inhibits the TLR2 signaling pathway to test its ability to suppress excessive activation of microglia. These studies will advance our understanding of a key molecular pathway involved in brain inflammation in people with Alzheimer's disease.